This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Reported reason: Shortage of an active ingredient
Product Information
DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Oryza Pharmaceuticals Inc., priced at $0.3031 per EA under NDC 72516001101. Its NADAC has been published 268 times since Mar 24, 2021.
FDA first approved this application on Apr 3, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAMIN 30 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine SulfateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Oryza Pharmaceuticals Inc.NDC
72516001101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA210293FDA Approved
4/3/2020
TE Code
AB
On Market Since
10/19/2020
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 268 times since Mar 24, 2021, and over the history we have for it it has declined 25.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3031 per EA |
|---|---|
| All-time high | $0.4093 (Apr 14, 2021) |
| All-time low | $0.2416 (Jul 17, 2024) |
| 52-week high | $0.3250 |
| 52-week low | $0.2992 |
| Median price | $0.3134 |
| Average price | $0.3166 |
| Largest weekly change | -26.9% (Nov 20, 2024) |
| Weeks tracked | 268 |
| Tracking since | Mar 24, 2021 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Oryza Pharmaceuticals Inc., is $0.3031 per EA (NDC 72516001101), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 25.9%. It has been tracked across 268 weekly CMS publications since Mar 24, 2021.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?
Since Mar 24, 2021, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2416 (Jul 17, 2024) to a high of $0.4093 (Apr 14, 2021), with a median of $0.3134 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAMIN 30 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?
DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 72516001101) is labeled by Oryza Pharmaceuticals Inc., and CMS classifies it as a generic product.
Is DEXTROAMP-AMPHETAMIN 30 MG TAB in shortage?
Yes — NDC 72516001101 is currently listed in FDA's drug shortage database (posted Oct 12, 2022). Reported reason: Shortage of an active ingredient.